title: Evolving concepts in tumour lysis syndrome management - response to Ayed et al.
authors.affiliation: Department of Haematology, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. gail.jones@nuth.nhs.uk.
authors.forename: Gail L
authors.initials: GL
authors.lastname: Jones
authors.affiliation: Department of Haematology, Royal Manchester Children's Hospital, Manchester, UK.
authors.forename: Andrew
authors.initials: A
authors.lastname: Will
authors.affiliation: Department of Haematology, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
authors.forename: Graham H
authors.initials: GH
authors.lastname: Jackson
authors.affiliation: Department of Nephrology, Royal Manchester Children's Hospital, Manchester, UK.
authors.forename: Nicholas J
authors.initials: NJ
authors.lastname: Webb
authors.affiliation: Department of Haematology, Derriford Hospital, Plymouth, Devon, UK.
authors.forename: Simon
authors.initials: S
authors.lastname: Rule
mesh_terms: D006801:Humans; D012307:Risk Factors; D015275:Tumor Lysis Syndrome
keywords: chemotherapy; immunotherapy; malignant haematology